This week on Contemporary OB/GYN®: Nov. 8 to Nov. 12
What to watch for this week on Contemporary OB/GYN®
vNOTES: where does it fit in the gynecologic surgery armamentarium?
In this month's technology-focused issue, we hear from Deputy Editor Jon I. Einarsson, MD, PHD, MPH, about his experience with vNOTES (vaginal natural orifice transluminal endoscopic surgery)."The reality is that traditional laparoscopic surgery provides excellent outcomes, great surgical exposure, and the flexibility to tackle almost any clinical situation. As such it is a high bar to overcome—vNOTES is essentially single port vaginal surgery."
Lack of health insurance directly reduces cancer screening rates, most recent and long-term
Disparities across the globe continue to surface as we approach year 2 of the COVID-19 pandemic, especially in the health care. As one considers its implications, a research team from the American Cancer Society investigated its potential impact on early cancer detection.
FDA-approved Brexafemme® as the first fungicidal medication for VVC treatment
In this video, Barb Dehn, NP, discusses Brexafemme®, the first fungicidal medication approved for the treatment of vulvovaginal candidiasis.
Robotic-assisted surgery for gynecologic procedures
“Today, many of these cases are done as open surgery, including approximately 60% of all hysterectomies performed globally, despite the clear benefits of minimally invasive surgery, which includes fewer complications, a shorter hospital stay, and a faster return to normal activities,” Peron told Contemporary OB/GYN®.